Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
Active, not recruiting · NCT06481280 · Registry updated 2025-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA. | Cow's Milk Allergy, Hypersensitivity, Immediate, Milk Hypersensitivity, food allergy, idiopathic generalized epilepsy, immune system disorder, orofacial cleft 1 | Active, not recruiting | Not applicable | 2025-01-07 | NCT06481280 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Slb Pharma | 9 |
| United Pharmaceuticals | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Private practice Elena BRADATAN | Namur | Belgium | 1 |
| University Hospital - Umberto I Sapienza | Roma | Italy | 1 |